These outcomes, along with a prior report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 assist the concept of concentrating on ACKR3 as a singular strategy to modulate the opioid process, which could open new therapeutic avenues for opioid-associated disorders.A investigate review published in Ane